William Thompson
Family Medicine · Stoystown, PANPI 1669427878
Payments from drug & device makers
Across 409 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$910
- Novo Nordisk$803
- Stryker$788
- Lilly USA, LLC$562
- GSK$530
- E.r. Squibb & Sons, L.L.C.$476
- plus $3K from 24 others
What the payments were for
- Travel & lodging$78811%
- Food & beverage$6,29889%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 51 | $910 |
| Novo Nordisk | 51 | $803 |
| Stryker | 2 | $788 |
| Lilly USA, LLC | 41 | $562 |
| GSK | 46 | $530 |
| E.r. Squibb & Sons, L.L.C. | 29 | $476 |
| Pfizer | 25 | $395 |
| AbbVie(2 entities) | 25 | $356 |
| Merck | 21 | $328 |
| Boehringer Ingelheim | 20 | $321 |
| Johnson & Johnson | 21 | $310 |
| Amgen | 12 | $199 |
| Exact Sciences | 6 | $132 |
| Sanofi-aventis U.S. LLC | 10 | $132 |
| Astellas Pharma US Inc | 7 | $129 |
| Novartis | 8 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $117 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 5 | $64 |
| Bayer | 3 | $60 |
| Abbott | 3 | $54 |
| Amarin Pharma, Inc. | 3 | $41 |
| UCB, Inc. | 1 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $20 |
| Linus Health, Inc. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$788
How this compares
$7,087 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 164 | $139,858 |
| JardianceEmpagliflozin | 148 | $133,716 |
| OzempicSemaglutide | 95 | $127,405 |
| TrulicityDulaglutide | 96 | $111,399 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 77 | $57,812 |
| FarxigaDapagliflozin Propanediol | 43 | $38,197 |
| EntrestoSacubitril/Valsartan | 39 | $30,954 |
| MounjaroTirzepatide | 24 | $27,717 |
| TradjentaLinagliptin | 28 | $24,774 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 28 | $24,628 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $19,204 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 34 | $16,543 |
| JanuviaSitagliptin Phosphate | 26 | $16,027 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $15,348 |
| MyrbetriqMirabegron | 25 | $12,300 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Combivent Respimat, Jentadueto Xr | $321 | $197,002232 claims |
| PfizerEliquis, Dilantin | $395 | $143,233176 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $562 | $139,116120 claims |
| Novo NordiskOzempic | $803 | $127,40595 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $530 | $105,278165 claims |
| AstraZenecaFarxiga, Symbicort | $910 | $41,74255 claims |
| NovartisEntresto | $126 | $30,95439 claims |
| MerckJanuvia, Janumet Xr | $328 | $23,91538 claims |
| Astellas Pharma US IncMyrbetriq | $129 | $12,30025 claims |
| Johnson & JohnsonXarelto | $310 | $11,65512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Stoystown
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.